ASIC4
gene geneOn this page
Also known as BNAC4
Summary
ASIC4 (acid sensing ion channel subunit family member 4, HGNC:21263) is a protein-coding gene on chromosome 2q35, encoding Acid-sensing ion channel 4 (Q96FT7). Does not exhibit measurable stand-alone pH-gated sodium channel activity but may form pH-gated heterotrimeric sodium channels.
This gene belongs to the superfamily of acid-sensing ion channels, which are proton-gated, amiloride-sensitive sodium channels. These channels have been implicated in synaptic transmission, pain perception as well as mechanoperception. This gene is predominantly expressed in the pituitary gland, and was considered a candidate for paroxysmal dystonic choreoathetosis (PDC), a movement disorder, however, no correlation was found between mutations in this gene and PDC.
Source: NCBI Gene 55515 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 13 total
- MANE Select transcript:
NM_018674
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21263 |
| Approved symbol | ASIC4 |
| Name | acid sensing ion channel subunit family member 4 |
| Location | 2q35 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | BNAC4 |
| Ensembl gene | ENSG00000072182 |
| Ensembl biotype | protein_coding |
| OMIM | 606715 |
| Entrez | 55515 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 3 protein_coding, 2 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000347842, ENST00000358078, ENST00000461395, ENST00000473709, ENST00000474489, ENST00000693692
RefSeq mRNA: 2 — MANE Select: NM_018674
NM_018674, NM_182847
CCDS: CCDS2442, CCDS33384
Canonical transcript exons
ENST00000358078 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000786129 | 219537632 | 219537736 |
| ENSE00001181728 | 219514482 | 219515306 |
| ENSE00001331872 | 219537933 | 219538772 |
| ENSE00002392208 | 219537242 | 219537321 |
| ENSE00003512191 | 219532883 | 219532939 |
| ENSE00003548274 | 219537066 | 219537157 |
| ENSE00003550735 | 219531758 | 219531902 |
| ENSE00003577635 | 219532315 | 219532477 |
| ENSE00003586548 | 219535171 | 219535324 |
| ENSE00003673055 | 219532001 | 219532128 |
Expression profiles
Bgee: expression breadth ubiquitous, 131 present calls, max score 88.63.
FANTOM5 (CAGE): breadth broad, TPM avg 2.1418 / max 125.7250, expressed in 232 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 25518 | 1.2462 | 151 |
| 25519 | 0.4440 | 93 |
| 25517 | 0.3991 | 170 |
| 202577 | 0.0524 | 26 |
Top tissues by expression
261 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| pituitary gland | UBERON:0000007 | 88.63 | gold quality |
| adenohypophysis | UBERON:0002196 | 86.75 | gold quality |
| vena cava | UBERON:0004087 | 82.67 | gold quality |
| type B pancreatic cell | CL:0000169 | 82.00 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 80.74 | gold quality |
| olfactory bulb | UBERON:0002264 | 80.74 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 80.74 | gold quality |
| cerebellar cortex | UBERON:0002129 | 80.45 | gold quality |
| amygdala | UBERON:0001876 | 80.35 | gold quality |
| cerebellum | UBERON:0002037 | 79.49 | gold quality |
| cingulate cortex | UBERON:0003027 | 79.05 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 79.00 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 78.65 | silver quality |
| tongue squamous epithelium | UBERON:0006919 | 78.50 | gold quality |
| body of tongue | UBERON:0011876 | 77.45 | gold quality |
| pons | UBERON:0000988 | 77.00 | gold quality |
| right frontal lobe | UBERON:0002810 | 76.94 | gold quality |
| hypothalamus | UBERON:0001898 | 76.46 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 76.45 | gold quality |
| substantia nigra | UBERON:0002038 | 75.96 | gold quality |
| tongue | UBERON:0001723 | 75.91 | gold quality |
| nucleus accumbens | UBERON:0001882 | 75.86 | gold quality |
| midbrain | UBERON:0001891 | 75.84 | gold quality |
| prefrontal cortex | UBERON:0000451 | 75.68 | gold quality |
| gluteal muscle | UBERON:0002000 | 75.40 | silver quality |
| brain | UBERON:0000955 | 75.07 | gold quality |
| temporal lobe | UBERON:0001871 | 75.04 | gold quality |
| triceps brachii | UBERON:0001509 | 74.96 | gold quality |
| cardia of stomach | UBERON:0001162 | 74.91 | gold quality |
| forebrain | UBERON:0001890 | 74.79 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7316 | yes | 31.77 |
| E-GEOD-137537 | yes | 17.58 |
| E-ANND-3 | yes | 3.11 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- Data show that transfected ASIC4 is targeted to the plasma membrane in CHO-K1 cells, where it associates with ASIC1a and downregulates exogenous ASIC1a expression. (PMID:18662336)
- Acid-sensing ion channel (ASIC) 4 predominantly localizes to an early endosome-related organelle upon heterologous expression (PMID:26667795)
Cross-species orthologs
28 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | asic4b | ENSDARG00000004243 |
| danio_rerio | asic4a | ENSDARG00000025162 |
| mus_musculus | Asic4 | ENSMUSG00000033007 |
| rattus_norvegicus | Asic4 | ENSRNOG00000019985 |
| drosophila_melanogaster | Nach | FBGN0024319 |
| drosophila_melanogaster | ppk28 | FBGN0030795 |
| drosophila_melanogaster | ppk17 | FBGN0032602 |
| drosophila_melanogaster | ppk6 | FBGN0034489 |
| drosophila_melanogaster | ppk12 | FBGN0034730 |
| drosophila_melanogaster | ppk29 | FBGN0034965 |
| drosophila_melanogaster | ppk24 | FBGN0039839 |
| drosophila_melanogaster | ppk22 | FBGN0051105 |
| drosophila_melanogaster | ppk8 | FBGN0052792 |
| drosophila_melanogaster | ppk5 | FBGN0053289 |
| drosophila_melanogaster | ppk16 | FBGN0065108 |
| drosophila_melanogaster | ppk11 | FBGN0065109 |
| drosophila_melanogaster | ppk9 | FBGN0085398 |
| drosophila_melanogaster | ppk18 | FBGN0265001 |
| caenorhabditis_elegans | WBGENE00003168 | |
| caenorhabditis_elegans | WBGENE00003174 | |
| caenorhabditis_elegans | WBGENE00007518 | |
| caenorhabditis_elegans | WBGENE00009073 | |
| caenorhabditis_elegans | WBGENE00011891 | |
| caenorhabditis_elegans | delm-2 | WBGENE00016063 |
| caenorhabditis_elegans | acd-1 | WBGENE00016064 |
| caenorhabditis_elegans | acd-2 | WBGENE00016066 |
| caenorhabditis_elegans | WBGENE00016699 | |
| caenorhabditis_elegans | WBGENE00017879 |
Paralogs (8): ASIC2 (ENSG00000108684), ASIC1 (ENSG00000110881), SCNN1A (ENSG00000111319), SCNN1D (ENSG00000162572), SCNN1G (ENSG00000166828), SCNN1B (ENSG00000168447), ASIC3 (ENSG00000213199), ASIC5 (ENSG00000256394)
Protein
Protein identifiers
Acid-sensing ion channel 4 — Q96FT7 (reviewed: Q96FT7)
Alternative names: Amiloride-sensitive cation channel 4, Amiloride-sensitive cation channel 4, pituitary
All UniProt accessions (2): Q96FT7, A0A8I5KPF5
UniProt curated annotations — full annotation on UniProt →
Function. Does not exhibit measurable stand-alone pH-gated sodium channel activity but may form pH-gated heterotrimeric sodium channels. Its activity could also depend on alternative gating mechanisms.
Subunit / interactions. Homotrimer. Heterotrimer; with other ASIC proteins producing functional channels.
Subcellular location. Cell membrane.
Tissue specificity. Expressed in pituitary gland. Weakly expressed in brain, vestibular system and organ of Corti.
Similarity. Belongs to the amiloride-sensitive sodium channel (TC 1.A.6) family. ASIC4 subfamily.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q96FT7-4 | 3 | yes |
| Q96FT7-1 | 1 | |
| Q96FT7-2 | 2 |
RefSeq proteins (2): NP_061144, NP_878267 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001873 | ENaC | Family |
| IPR020903 | ENaC_CS | Conserved_site |
Pfam: PF00858
UniProt features (24 total): disulfide bond 7, topological domain 3, glycosylation site 3, splice variant 3, sequence variant 3, transmembrane region 2, chain 1, region of interest 1, short sequence motif 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96FT7-F1 | 80.37 | 0.52 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (7): 118–202, 180–187, 296–375, 318–371, 322–369, 331–353, 333–345
Glycosylation sites (3): 376, 191, 243
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-2672351 | Stimuli-sensing channels |
| R-HSA-382551 | Transport of small molecules |
| R-HSA-983712 | Ion channel transport |
MSigDB gene sets: 87 (showing top):
GOBP_BEHAVIOR, GOBP_SODIUM_ION_TRANSMEMBRANE_TRANSPORT, AREB6_03, GOBP_MULTICELLULAR_ORGANISMAL_RESPONSE_TO_STRESS, GOBP_MONOATOMIC_CATION_TRANSPORT, GOBP_FEAR_RESPONSE, HP1SITEFACTOR_Q6, NKX22_01, GOBP_TRANSMEMBRANE_TRANSPORT, GOBP_SODIUM_ION_TRANSPORT, SHEN_SMARCA2_TARGETS_DN, GOMF_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_GATED_CHANNEL_ACTIVITY, GOMF_PASSIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_MONOATOMIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY
GO Biological Process (5): behavioral fear response (GO:0001662), sodium ion transmembrane transport (GO:0035725), monoatomic ion transport (GO:0006811), sodium ion transport (GO:0006814), monoatomic ion transmembrane transport (GO:0034220)
GO Molecular Function (3): ligand-gated sodium channel activity (GO:0015280), sodium channel activity (GO:0005272), protein binding (GO:0005515)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Ion channel transport | 1 |
| Transport of small molecules | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| behavioral defense response | 1 |
| fear response | 1 |
| sodium ion transport | 1 |
| monoatomic cation transmembrane transport | 1 |
| transport | 1 |
| metal ion transport | 1 |
| monoatomic ion transport | 1 |
| transmembrane transport | 1 |
| sodium channel activity | 1 |
| ligand-gated monoatomic cation channel activity | 1 |
| monoatomic cation channel activity | 1 |
| sodium ion transmembrane transporter activity | 1 |
| binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
664 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ASIC4 | PNKD | Q8N490 | 890 |
| ASIC4 | HAGH | Q16775 | 767 |
| ASIC4 | ASIC2 | Q16515 | 699 |
| ASIC4 | ASIC3 | Q9UHC3 | 699 |
| ASIC4 | SLC4A3 | P48751 | 640 |
| ASIC4 | TRPV1 | Q8NER1 | 564 |
| ASIC4 | EHBP1L1 | Q8N3D4 | 509 |
| ASIC4 | BUD13 | Q9BRD0 | 486 |
| ASIC4 | CAMTA1 | Q9Y6Y1 | 458 |
| ASIC4 | ZPR1 | O75312 | 449 |
| ASIC4 | APOA5 | Q6Q788 | 425 |
| ASIC4 | TNFSF10 | P50591 | 414 |
| ASIC4 | GPR65 | Q8IYL9 | 414 |
| ASIC4 | GPR4 | P46093 | 400 |
| ASIC4 | TRPV4 | Q9HBA0 | 383 |
IntAct
10 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| OTX2 | ASIC4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ASIC4 | psi-mi:“MI:0915”(physical association) | 0.400 | |
| CFTR | ASIC4 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ASIC4 | UPK3BL1 | psi-mi:“MI:0914”(association) | 0.350 |
| ASIC4 | TMEM131L | psi-mi:“MI:0914”(association) | 0.350 |
| ASIC4 | CLGN | psi-mi:“MI:0914”(association) | 0.350 |
| ASIC4 | OTX2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (167): ASIC4 (Two-hybrid), HSPA14 (Affinity Capture-MS), TMEM8A (Affinity Capture-MS), ADCY3 (Affinity Capture-MS), TMEM231 (Affinity Capture-MS), CNNM1 (Affinity Capture-MS), ITPRIP (Affinity Capture-MS), ABCA3 (Affinity Capture-MS), LRP12 (Affinity Capture-MS), GABRB3 (Affinity Capture-MS), CLPTM1 (Affinity Capture-MS), EIF2AK3 (Affinity Capture-MS), TSPAN6 (Affinity Capture-MS), GLB1L2 (Affinity Capture-MS), ALG9 (Affinity Capture-MS)
ESM2 similar proteins: A0A287A2K5, F1MV99, O08858, O43193, O77808, O97772, P28646, P30098, P30552, P30553, P30796, P30872, P30873, P30937, P30938, P31391, P32239, P32300, P32307, P32745, P33533, P35346, P35370, P35377, P41143, P41146, P46095, P46627, P47748, P48044, P49660, P51651, P56481, P58406, P79266, P79292, Q49LX5, Q5D0K2, Q6W5G4, Q6YNI2
Diamond homologs: O35240, P55926, P78348, Q10025, Q16515, Q1XA76, Q62962, Q6NXK8, Q6X1Y6, Q708S3, Q708S4, Q708S5, Q708S6, Q708S7, Q708S8, Q7T1N4, Q7TNS7, Q925H0, Q96FT7, Q9JHS6, Q9NY37, Q9R0W5, Q9R0Y1, Q9UHC3, Q25011, H1AFJ5, H2Q5A1, H9GBX2, K7GET2, O13263, O97741, P24585, P24612, P34886, P37088, P37089, P51169, P51171, P51172, Q09274
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
13 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 2 |
| Likely benign | 3 |
| Benign | 4 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1894 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:219515304:GTG:G | donor_gain | 1.0000 |
| 2:219531872:G:GT | donor_gain | 1.0000 |
| 2:219531895:G:GT | donor_gain | 1.0000 |
| 2:219531898:GACAA:G | donor_gain | 1.0000 |
| 2:219531903:G:GG | donor_gain | 1.0000 |
| 2:219531916:A:T | donor_gain | 1.0000 |
| 2:219531921:G:T | donor_gain | 1.0000 |
| 2:219532125:GCGG:G | donor_gain | 1.0000 |
| 2:219532126:CGGGT:C | donor_loss | 1.0000 |
| 2:219532127:GG:G | donor_gain | 1.0000 |
| 2:219532127:GGGT:G | donor_loss | 1.0000 |
| 2:219532128:GG:G | donor_gain | 1.0000 |
| 2:219532129:GTGA:G | donor_loss | 1.0000 |
| 2:219532130:T:G | donor_loss | 1.0000 |
| 2:219537153:GCTGG:G | donor_gain | 1.0000 |
| 2:219537156:GG:G | donor_gain | 1.0000 |
| 2:219537157:GG:G | donor_gain | 1.0000 |
| 2:219537158:G:GG | donor_gain | 1.0000 |
| 2:219537158:GTG:G | donor_loss | 1.0000 |
| 2:219537159:T:A | donor_loss | 1.0000 |
| 2:219537236:TCCCA:T | acceptor_loss | 1.0000 |
| 2:219537239:CAG:C | acceptor_loss | 1.0000 |
| 2:219537240:A:AC | acceptor_loss | 1.0000 |
| 2:219537240:A:AG | acceptor_gain | 1.0000 |
| 2:219537241:G:GG | acceptor_gain | 1.0000 |
| 2:219537241:G:GT | acceptor_loss | 1.0000 |
| 2:219537241:GGA:G | acceptor_gain | 1.0000 |
| 2:219537597:T:A | acceptor_gain | 1.0000 |
| 2:219515304:GTGGT:G | donor_loss | 0.9900 |
| 2:219515305:TG:T | donor_gain | 0.9900 |
AlphaMissense
4295 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:219515068:T:A | V242D | 1.000 |
| 2:219515076:T:A | C245S | 1.000 |
| 2:219515076:T:C | C245R | 1.000 |
| 2:219515077:G:A | C245Y | 1.000 |
| 2:219515077:G:C | C245S | 1.000 |
| 2:219515077:G:T | C245F | 1.000 |
| 2:219515078:C:G | C245W | 1.000 |
| 2:219515081:T:A | N246K | 1.000 |
| 2:219515081:T:G | N246K | 1.000 |
| 2:219515087:C:A | N248K | 1.000 |
| 2:219515087:C:G | N248K | 1.000 |
| 2:219515131:T:C | L263P | 1.000 |
| 2:219515227:G:C | R295P | 1.000 |
| 2:219515263:G:A | C307Y | 1.000 |
| 2:219515264:C:G | C307W | 1.000 |
| 2:219515299:T:G | F319C | 1.000 |
| 2:219531773:G:T | G327W | 1.000 |
| 2:219531774:G:A | G327E | 1.000 |
| 2:219531774:G:T | G327V | 1.000 |
| 2:219531779:T:A | C329S | 1.000 |
| 2:219531779:T:C | C329R | 1.000 |
| 2:219531780:G:A | C329Y | 1.000 |
| 2:219531780:G:C | C329S | 1.000 |
| 2:219531780:G:T | C329F | 1.000 |
| 2:219531781:T:G | C329W | 1.000 |
| 2:219531789:T:C | F332S | 1.000 |
| 2:219531846:T:C | L351P | 1.000 |
| 2:219531858:T:C | L355P | 1.000 |
| 2:219531892:G:C | W366C | 1.000 |
| 2:219531892:G:T | W366C | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000076930 (2:219519223 G>A), RS1000274658 (2:219509129 A>T), RS1000338083 (2:219531348 A>T), RS1000365468 (2:219524771 C>A,T), RS1000366696 (2:219521066 C>G), RS1000439878 (2:219515879 C>T), RS1000461830 (2:219522419 A>C,G), RS1000525302 (2:219517920 G>A), RS1000629898 (2:219507070 AT>A), RS1000658935 (2:219527377 G>A), RS1000699157 (2:219523332 C>T), RS1000784527 (2:219535489 T>C), RS1000876854 (2:219530962 G>A), RS1001078362 (2:219530016 C>G,T), RS1001192475 (2:219535274 C>G)
Disease associations
OMIM: gene MIM:606715 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007429_71 | Lung function (FVC) | 3.000000e-10 |
| GCST009246_131 | Cerebrospinal fluid sTREM-2 levels | 4.000000e-12 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004312 | vital capacity |
| EFO:0010151 | soluble triggering receptor expressed on myeloid cells 2 measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
15 total (human), top 15 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, increases expression, increases methylation | 2 |
| aristolochic acid I | increases expression | 1 |
| pirinixic acid | affects binding, decreases expression, increases activity | 1 |
| sodium arsenite | increases expression | 1 |
| licochalcone B | increases expression | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| theaflavin-3,3’-digallate | affects expression | 1 |
| Atrazine | increases expression | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation, increases methylation | 1 |
| Cisplatin | affects cotreatment, decreases expression | 1 |
| Hydralazine | affects cotreatment, increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Toluene | decreases expression, increases methylation | 1 |
| Tretinoin | increases expression | 1 |
| Triclosan | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.